Table 2.
Baseline characteristics of the study groups
| Characteristics | Mepridin (n = 75) | Control (n = 75) | p value |
|---|---|---|---|
| Age (years)a | 35.1 ± 3.7 | 34.7 ± 3.9 | 0.4 |
| Gestational age (weeks)a | 39.2 ± 1.5 | 39.4 ± 1.1 | 0.7 |
| Cervical dilatation (cm)a | 3.7 ± 3.4 | 4.1 ± 3.7 | 0.2 |
| Parityb | |||
| Nullipara | 35 (46.7) | 31 (41.3) | 0.09 |
| Multipara | 40 (53.3) | 44 (58.7) | 0.09 |
| Oxytocin augmentationb | 52 (69.3) | 49 (65.3) | 0.6 |
| Birth weight (g)a | 3080 ± 475 | 3101 ± 400 | 0.7 |
| Apgar (first 10 min)a | 7.9 ± 2.0 | 7.4 ± 2.5 | 0.5 |
a
mean ± SD;
b
number (%).